Kronos Bio

Kronos Bio is an American oncology target screening platform dedicated to transforming scientific research achievements into a high-throughput screening strategy for chemical modulators of transcription factors and other extremely challenging targets in the oncology field. It leverages its Small Molecule Microarray (SMM) platform and biological assay technologies to develop new drugs that address difficult-to-control targets in cancer research.